Changchun High-Tech Industries (Group) Inc., together with its subsidiaries, researches, develops, manufactures, and sells pharmaceutical products in China. The company provides genetic engineering pharmaceuticals, biological vaccines, modern Chinese medicines, and other pharmaceutical products. It also develops real estate properties. The company was formerly known as Changchun High & New Technology Industry (Group) Inc. Changchun High-Tech Industries (Group) Inc. was founded in 1993 and is based in Changchun, China.
Stock data | 2024 | Change |
---|---|---|
Price | $11.39 | N/A |
Market Cap | $4.61B | N/A |
Shares Outstanding | 404.66M | N/A |
Employees | 8.84K | N/A |
Valuation | 2024 | Change |
---|---|---|
P/FCF | 11.89 | N/A |
Dividends | 2024 | Change |
---|---|---|
Dividend Yield | 1.35% | N/A |
Dividend per share | 0.1533 | N/A |
Growth | 2024 | Change |
---|---|---|
CAPEX | -296.40M | N/A |
Earnings | 2024 | Change |
---|---|---|
Free Cash Flow | $387.65M | N/A |